Fear of Suits Blocks Retractions

WASHINGTON—The fear of lawsuits is blocking efforts to purge the scientific literature of articles by psychologist Stephen Breuning that are based on fraudulent data. The National Institute of Mental Health concluded this spring that Breuning “knowingly, willfully and repeatedly engaged in misleading and deceptive practices in reporting results of research.” Although all journal editors who published Breuning’s questionable papers were sent copies of the NIMH report, on

Written byAj Hostetler
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—The fear of lawsuits is blocking efforts to purge the scientific literature of articles by psychologist Stephen Breuning that are based on fraudulent data. The National Institute of Mental Health concluded this spring that Breuning “knowingly, willfully and repeatedly engaged in misleading and deceptive practices in reporting results of research.” Although all journal editors who published Breuning’s questionable papers were sent copies of the NIMH report, only a few of the editors or the co-authors have considered, or attempted to publish, retractions.

Breuning’s misconduct involves more than 50 publications. A prolific researcher on the effects of neuroleptics on the mentally retarded, Breuning wrote more than one-third of the papers in his field from 1979 to 1983, according to NIMH’s Pharmacotherapy and Mental Retardation Bibliography, as well as several books on the topic.

The NIMH investigation concluded that many of those studies were never conducted. The Justice Department is expected to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies